These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 27177192)
21. Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods. Zemanick ET; Wagner BD; Robertson CE; Stevens MJ; Szefler SJ; Accurso FJ; Sagel SD; Harris JK Ann Am Thorac Soc; 2015 Feb; 12(2):221-9. PubMed ID: 25474078 [TBL] [Abstract][Full Text] [Related]
22. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772 [TBL] [Abstract][Full Text] [Related]
23. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response. Ciofu O APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154 [TBL] [Abstract][Full Text] [Related]
24. Lung Microbiota Changes Associated with Chronic Pseudomonas aeruginosa Lung Infection and the Impact of Intravenous Colistimethate Sodium. Collie D; Glendinning L; Govan J; Wright S; Thornton E; Tennant P; Doherty C; McLachlan G PLoS One; 2015; 10(11):e0142097. PubMed ID: 26544950 [TBL] [Abstract][Full Text] [Related]
25. Commensal Bacteria in the Cystic Fibrosis Airway Microbiome Reduce Tony-Odigie A; Wilke L; Boutin S; Dalpke AH; Yi B Front Cell Infect Microbiol; 2022; 12():824101. PubMed ID: 35174108 [TBL] [Abstract][Full Text] [Related]
26. Vancomycin-induced gut dysbiosis during Pseudomonas aeruginosa pulmonary infection in a mice model. Rosa CP; Pereira JA; Cristina de Melo Santos N; Brancaglion GA; Silva EN; Tagliati CA; Novaes RD; Corsetti PP; de Almeida LA J Leukoc Biol; 2020 Jan; 107(1):95-104. PubMed ID: 31682032 [TBL] [Abstract][Full Text] [Related]
27. Signal transducer and activator of transcription 4 (STAT4), but not IL-12 contributes to Pseudomonas aeruginosa-induced lung inflammation in mice. O'Sullivan R; Carrigan SO; Marshall JS; Lin TJ Immunobiology; 2008; 213(6):469-79. PubMed ID: 18514749 [TBL] [Abstract][Full Text] [Related]
28. A chronic rhinosinusitis-derived isolate of Pseudomonas aeruginosa induces acute and pervasive effects on the murine upper airway microbiome and host immune response. Cope EK; Goldberg AN; Pletcher SD; Lynch SV Int Forum Allergy Rhinol; 2016 Dec; 6(12):1229-1237. PubMed ID: 27598436 [TBL] [Abstract][Full Text] [Related]
30. The immunoevasive activities of Pseudomonas aeruginosa. Relevance for cystic fibrosis. Buret A; Cripps AW Am Rev Respir Dis; 1993 Sep; 148(3):793-805. PubMed ID: 8368651 [No Abstract] [Full Text] [Related]
31. Pathophysiological changes induced by Pseudomonas aeruginosa infection are involved in MMP-12 and MMP-13 upregulation in human carcinoma epithelial cells and a pneumonia mouse model. Park JW; Shin IS; Ha UH; Oh SR; Kim JH; Ahn KS Infect Immun; 2015 Dec; 83(12):4791-9. PubMed ID: 26438797 [TBL] [Abstract][Full Text] [Related]
32. Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung. Hogardt M; Heesemann J Curr Top Microbiol Immunol; 2013; 358():91-118. PubMed ID: 22311171 [TBL] [Abstract][Full Text] [Related]
33. The cystic fibrosis lung microbiome. Surette MG Ann Am Thorac Soc; 2014 Jan; 11 Suppl 1():S61-5. PubMed ID: 24437409 [TBL] [Abstract][Full Text] [Related]
35. How mutant CFTR may contribute to Pseudomonas aeruginosa infection in cystic fibrosis. Pier GB; Grout M; Zaidi TS; Goldberg JB Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 2):S175-82. PubMed ID: 8876538 [TBL] [Abstract][Full Text] [Related]